Roche (OTC: RHHBY) announced today that it has received FDA clearance for the cobas® Factor II and Factor V Test ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE